Cancer Research UK logo.
SearchDonate
  • Search

A trial of a new drug called IMCgp100 for people with a type of eye cancer called uveal melanoma

Overview

Cancer types:

Eye cancer, Melanoma, Melanoma of the eye, Secondary cancers

Status:

Closed

Phase:

Phase 2

Details

This trial is for people with uveal melanoma that has spread to other parts of the body (advanced uveal melanoma). It is for people who are going to have treatment for the first time.

Recruitment start: 24 January 2018

Recruitment end: 19 June 2020

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Joseph Sacco

Dr Paul Nathan

Dr Jeffrey Evans

Supported by

Immunocore

Last reviewed: 22 Jun 2020

CRUK internal database number: 15581

Help and support